Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Optherion raises $37 million

Optherion (New Haven, Conn.) raised $37 million in a series A round led

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE